Helpline
Call 1.855.378.4373 to schedule a call time with a specialist or visit scheduler.drugfree.org
Helpline
Helpline
Call 1.855.378.4373 to schedule a call time with a specialist

The Latest News from Our Field

We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.

The U.S. Food and Drug Administration on Wednesday approved the first over-the-counter naloxone nasal spray, The New York Times reports.
Test strips will soon be available to detect the presence of the animal sedative xylazine, also known as tranq, in illicit substances, STAT reports.
People who survive an opioid overdose have a lower risk of dying from a subsequent overdose if they are treated with the opioid addiction medication buprenorphine, a new study suggests.
Find more of our must-reads in policy news, including the FDA approving Narcan naloxone nasal spray for over-the-counter, nonprescription use.
View our curated digest of the latest research news, including a study on the ecological momentary assessment of heavy episodic drinking in the early postpartum period by Sarah Dauber, Vice President of Research and Evaluation at the Partnership to End Addiction.
The U.S. Drug Enforcement Administration this week issued a warning about the widespread threat of fentanyl mixed with the veterinary tranquilizer xylazine, CNN reports.
State legislators around the country are seeking harsher penalties for possessing fentanyl and other synthetic opioids, despite evidence showing harm reduction and treatment are needed more, AP reports.
California Governor Gavin Newsom is calling for a measure on the 2024 ballot that would fund a major expansion of housing and treatment for residents experiencing mental illness and substance use disorders, AP reports.
Find more of our must-reads in policy news, including the reintroduction of the Family Support Services for Addiction Act.
View our curated digest of the latest research news, including a case report on the association between delta-8 THC and psychosis.
Some pharmacies in northern Mexico that cater to U.S. tourists are selling medications that are laced with fentanyl and methamphetamine, according to a new study.
The $21 billion opioid settlement brokered last year between the three largest U.S. pharmaceutical distributors and the attorneys general of 46 states has made it more difficult for some patients to obtain other types of medications, including those for addiction, anxiety and attention deficit hyperactivity disorder, according to The New York Times.
The Department of Justice this week announced a suit against Rite Aid, alleging the pharmacy chain knowingly filled unlawful prescriptions for controlled substances, including opioids.
Find more of our must-reads in policy news, including distributor requirements from the opioid settlement that are hindering access to medications.
View our curated digest of the latest research news, including a survey on pod-based e-cigarette use among U.S. college-aged adults.
A new study finds that opioids were responsible for more than half of all fatal poisonings in children under age 5 in 2018. The rate of fatal opioid poisonings in young children has doubled since 2005, CNN reports.
Some addiction experts are hopeful that more patients will be treated with the opioid use disorder medication buprenorphine now that Congress has made it easier for doctors to prescribe it, NPR reports. But others are concerned stigma could undermine efforts to expand access.
Data from the Food and Drug Administration on its confiscation of packages containing substances coming through international mail shows few of them contain opioids, Kaiser Health News reports. The overwhelming majority of the packages were uncontrolled prescription medications that people had ordered, such as generic Viagra.
Find more of our must-reads in policy news, including the barriers that remain even after the elimination of the buprenorphine waiver.
View our curated digest of the latest research news, including a study on the impact of childhood trauma on problematic alcohol and drug use trajectories and the moderating role of social support.
The U.S. Food and Drug Administration announced this week it is taking action to restrict illegal importing of the veterinary pharmaceutical xylazine, which has increasingly been found in illicit fentanyl and involved in a growing number of overdose deaths.
The Drug Enforcement Administration is proposing to reinstate federal rules, waived during the pandemic, that require patients to see a doctor in person to receive an initial prescription for controlled medicines such as OxyContin or Adderall.
A new clinical trial will compare the ability of patients to remain in treatment for opioid addiction when prescribed buprenorphine or methadone in an office setting, STAT reports.
Find more of our must-reads in policy news, including the DEA proposing new rules for prescribing via telemedicine.
View our curated digest of the latest research news, including a study identifying the frequency of medications for opioid use disorder (MOUD) prior authorization prohibitions in state laws.
1 9 10 11 12 13 359